Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5372935011 | Product containing only bimekizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5372936012 | Bimekizumab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing only bimekizumab in parenteral dose form (medicinal product form) | Is a | Product containing only bimekizumab (medicinal product) | true | Inferred relationship | Some | ||
Product containing only bimekizumab in parenteral dose form (medicinal product form) | Is a | Product containing bimekizumab in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing only bimekizumab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
Product containing only bimekizumab in parenteral dose form (medicinal product form) | Has active ingredient | Bimekizumab (substance) | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Bimekizumab 160 mg/mL solution for injection | Is a | True | Product containing only bimekizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets